Skip to content

Homeopathic medicines for treatment of high blood sugar

Effects of Individualized Homoeopathic Medicines in Preventing the Progression from Pre-diabetes to Diabetes: A Double-blind, Randomized, Placebo-controlled, Parallel arm Pilot Trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/042026
Enrollment
60
Registered
2022-04-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R739- Hyperglycemia, unspecified

Interventions

Intervention1: Individualized homeopathic medicines in centesimal potencies: Intervention is planned as administering the Individualized Homeopathic Medicines in centesimal potencies. Each dose consis
dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing teeth within
dosage and repetition were maintained depending upon the individual requirement of the cases. All sundry items will be procured from a GMP certified firm. The patients will receive advices on lifestyl

Sponsors

D N De Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having pre-diabetes: HbA1c 5.7-6.4%, fasting blood glucose 100-125 mg/dl, impaired fasting glucose- 140-199 mg/dl (ICD-10 code R73.09). 2. Age: 18-65 years. 3. Sex: Both Male and Female. 4. Indian Diabetic Risk Score (IDRS) more than 60. 5. Literate patient; ability to read English or Bengali 6. Providing with written informed consent

Exclusion criteria

Exclusion criteria: 1. Patients having diabetes mellitus. 2. Currently undergoing anti-diabetic drug therapy 3. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any vital organ failure. 4. Patients with a habit of tobacco chewing and/ or smoking, alcoholism and/or any other form(s) of substance abuse and/or dependence. 5. Vulnerable population: unconscious,ambulatory, too sick for consultation, differently abled, terminally or critically ill patients, mentally incompetent people. 6. Self-reported immune-compromised state. 7. Dyslipidemia: Total cholesterol- more than 199 mg/dl of blood, triglycerides more than 150 mg/dl, LDL more than 100 mg/dl, VLDL more than 150 mg/dl. 8. Serum urea: more than 40 mg/dl of blood and serum creatinine more than 1.2 mg/dl of blood will be excluded. 9. Pregnant and puerperal women and lactating mothers. 10. Undergoing homeopathic treatment for any chronic disease within last 6 months. 11. Patients who are too sick for consultation.

Design outcomes

Primary

MeasureTime frame
The proportion of pre-diabetics converting into diabeticsTimepoint: After 3 months and 6 months

Secondary

MeasureTime frame
Fasting blood sugar, oral glucose tolerance test, HbA1C%, lipid profile, serum urea, creatinine, liver enzymes (ALT, AST)Timepoint: At baseline, after 3 months & 6 months;Measure Yourself Medical Outcome Profile 2 (MYMOP2) questionnaireTimepoint: At baseline, and after 3 months and 6 months

Countries

India

Contacts

Public ContactProf Dr Subhasish Ganguly

D N De Homoeopathic Medical College and Hospital

ganguly.subhasish@rediffmail.com9007263548

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026